Resolute System    

Log In
 
 

Forgot Your Password?
 


Not a member? Click here!

The ASTAMI Trial
Management of Perforations
BOOST: Intracoronary Autologous Bone-Marrow Cell Transfer after MI
Myoblast Transplantation with 12-Mo Follow Up
Progenitor Cells Healing I and II








 

 

Adenosine of AF Ablation – The New Kid on the Block

Arrhythmia recurrence is common following ablation for atrial fibrillation (AF). A strategy of adenosine infusion to unmask dormant conduction pathways in the pulmonary veins has been shown to reduce the recurrence of atrial tachyarrhythmias following AF ablation.

For more, click here

 

 

 

Surgical & Non-Surgical Centers Equally Safe for PCI

The safety and efficacy of percutaneous coronary intervention (PCI) at centers with and without surgical support have been the subject of much debate. Data from the British Cardiovascular Intervention Society database of 384,013 patients with a median follow-up of 3.4 centers have indicated similar mortality for both cohorts irrespective of procedural indication.


For more, click here

 

 

 

 

Novel Oral Anticoagulants & The Risk of Bleeding in Elderly Patients

The bleeding risk of novel oral anticoagulants relative to warfarin in patients ≥ 75 years of age is unknown. A systematic review and meta-analysis have indicated differing patterns of risk with dabigatran being associated with the highest risk for GI bleeding. There is currently insufficient data for the bleeding risk of apixaban, rivaroxaban, and edoxaban in this population.

For more, click here

 

 

 

Bystander CPR Improves Survival

Early cardiopulmonary resuscitation (CPR) and defibrillation improves survival following an out-of-hospital cardiac arrest (OOHCA). A statewide educational training has indicated that bystander initiated CPR will lead to a greater likelihood of survival and favorable neurological outcomes.

For more, click here

 

<
||
>











CRT2013
 
Relationship between hospital PTCA volume and in-hospital outcomes: Is it still true 9 years later?
- Christian Spaulding, M.D., FACC, FESC
The EGO-BioFreedom Study
- Stephen Lee, MD
Prosthesis-Patient Mismatch in High Risk Patients with Severe Aortic Stenosis in a Randomized Trial of a Self-Expanding Prosthesis
- George L. Zorn, III, MD
The Risk and Extent of Neurological Events Are Equivalent for High-Risk Patients Treated With Transcatheter or Surgical Aortic Valve Replacement
- Thomas G. Gleason, MD
Valve Thrombosis After TAVR: Frequency, Clinical Recognition, and Management
- Azeem Latib, MD


Live Case Demonstration from Kusatsu Heart Center
Osamu Hatoh, MD
Treating CTO via Radial?
Richard R. Heuser, MD
Patient Selection for CTO Recanalization: What Are the Appropriate Criteria?
Tarek Helmy, MD
Treating CTOs: Is There Enough Evidence-Based Data or do We Need Further Randomized Clinical Trials?
Gerald S. Werner, MD, PhD
Indication for CTO PCI: Clinical Rationale and Appropriateness
J. Aaron Grantham, MD
 Click here to visit the WEBEX archives


Plaque Characterization by Coronary Computed Tomography Angiography and the Likelihood of Acute Coronary Events in Mid-Term Follow-Up.
S Motoyama, et al.
JACC 2015; 66:337-346
Presentation, Diagnosis, and Outcomes of Acute Aortic Dissection: 17-Year Trends From the International Registry of Acute Aortic Dissection.
L Pape, et al.
JACC 2015; 66:350-358
Outcomes of Percutaneous Coronary Intervention Performed at Offsite Versus Onsite Surgical Centers in the United Kingdom.
S Garg, et al.
JACC 2015; 66:363-372
Sex Differences in the Rate, Timing, and Principal Diagnoses of 30-Day Readmissions in Younger Patients with Acute Myocardial Infarction.
R Dreyer, et al.
Circ 2015; 132:158-166
Perioperative Management of Dabigatran: A Prospective Cohort Study.
S Schulman, et al.
Circ 2015; 132:167-173
Association of Discharge Aspirin Dose With Outcomes After Acute Myocardial Infarction: Insights From the Treatment with ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) Study.
Y Xian, et al.
Circ 2015; 132:174-181
Efficacy and Harms of Direct Oral Anticoagulants in the Elderly for Stroke Prevention in Atrial Fibrillation and Secondary Prevention of Venous Thromboembolism: Systematic Review and Meta-Analysis.
M Sharma, et al.
Circ 2015; 132:194-204
Long-Term Outcomes of Abdominal Aortic Aneurysm in the Medicare Population.
M Schermerhorn, et al.
NEJM 2015; 373:328-338
Association of Bystander Interventions With Neurologically Intact Survival Among Patients With Bystander-Witnessed Out-of-Hospital Cardiac Arrest in Japan.
S Nakahara, et al.
JAMA 2015; 314:247-254
Association of Bystander and First-Responder Intervention With Survival After Out-of-Hospital Cardiac Arrest in North Carolina, 2010-2013.
C Hansen, et al.
JAMA 2015; 314:255-264
Adenosine-Guided Pulmonary Vein Isolation for the Treatment of Paroxysmal Atrial Fibrillation: An International, Multicentre, Randomised Superiority Trial.
L Macle, et al.
The Lancet 2015 Online



Poll Archives

Complex Patients Today and Tomorrow: Medtronic DES solutions from Resolute Integrity to bioresorbable stents
Prof. Sigmund Silber, MD
First Report on the Pivotal DESolve Nx trial: 6-month Clinical and Multimodality Imaging Results
Alexandre Abizaid, MD, PhD
One-Year Outcomes in 1010 Unselected Patients Treated with the PROMUS Element Everolimus-Eluting Stent: The Multicenter PROMUS Element European Post-Approval Surveillance Study
Raul Moreno, MD, et al.
Two-year clinical outcomes in the EVOLVE FHU trial
Ian Meredith, MD, PhD
BIOFLOW-II Trial
Stephan Windecker, MD, et al.

Outcomes in More Than 7000 Patients With Diabetes After Implantation of the Resolute Zotarolimus-eluting Stent
Rosli Mohd Ali, MD
Safety update and long-term clinical outcomes from all studies in the RESOLUTE Global Clinical Program
Carlo Di Mario, MD
Final Five-year Outcomes from the Randomized Comparison of Zotarolimus-eluting Stents With Everolimus-eluting Stents in the RESOLUTE All Comers Trial
Stephan Windecker, MD
Angina Status & TLF Creep: Bioabsorbable Stents (BAS) & Drug-Eluting Stents (DES)
Medtronic, Inc.
Clinical outcomes associated with dual antiplatelet therapy interruption following implantation of the ResoluteTM zotarolimus-eluting stent
Stephan Windecker, MD
Four-year Outcomes from the Randomized Comparison of a Zotarolimus-eluting and an Everolimus-eluting Stent in the RESOLUTE All Comers Trial
Patrick W Serruys MD, PhD
Resolute in Bifurcation Lesions: Data from the RESOLUTE Clinical Program
Prof. Ran Kornowski, MD



7/22/2015
Blue Cross Blue Shield Association Study Shows Cost Variations for PCI

7/22/2015
Hospira Launches Generic Bivalirudin in the United States

7/22/2015
FAST Enrollment Begins for Boston Scientific’s Fully Resorbable Drug-Eluting Scaffold

7/22/2015
First Patient Enrolled in OrbusNeich’s China Recovery Study

7/22/2015
Micell Technologies Announces First Patient Enrolled in Registration of MiStent SES in China

7/10/2015
Vygon Group Acquires Perouse Medical

7/10/2015
M2S and Medstreaming to Collaborate on Automated Interface for VQI’s Pathways Registry

7/10/2015
FDA Clears CSI’s Next-Generation ViperWire With Flex Tip

7/8/2015
Cardiac Dimensions announces initial enrolments in REDUCE FMR clinical trial

7/8/2015
New study will compare OCT with IVUS for guided stent placement

7/8/2015
Daiichi Sankyo’s Edoxaban Approved in Europe

7/8/2015
St. Jude Medical Begins ILUMIEN III Trial of OCT Imaging

7/8/2015
ABIM Will Discontinue Requirement for Maintaining Underlying Board Certification for Interventional Cardiology and 14 Other Subspecialties

7/8/2015
Enrollment of Initial Cohort Completed in Hansen Medical’s ARTISAN AF Clinical Trial

6/30/2015
Cardiac Dimensions Begins Enrollment for REDUCE FMR Trial of the Carillon Mitral Contour System

6/26/2015
Terumo Launches Misago RX Self-Expanding Peripheral Stent in United States

6/26/2015
Medtronic Acquires Aptus Endosystems for $110 Million

6/26/2015
Spectranetics Receives FDA Clearance for Larger-Diameter AngioSculpt Scoring Balloon

6/26/2015
FDA approves cangrelor, an intravenous antiplatelet drug

6/24/2015
FDA Approves the CoreValve® Evolut® R System

3/10/2015
Boston Scientific to Acquire American Medical Systems’ Urology Portfolio

3/10/2015
Vascutek to Distribute Vascular Flow Technologies’ Spiral Flow Grafts in Europe

1/5/2015
FDA Approves Medtronic’s In.Pact Admiral DCB to Treat SFA and Popliteal Artery Disease

12/18/2014
FDA Clears ReFlow Medical’s Spex Shapeable Support Catheter

12/11/2014
CSI Completes COAST Enrollment in Japan

12/11/2014
FDA Clears HeartFlow’s FFRCT Technology
ACS & AMI
Angiomyogenesis & Cell Therapy
Carotid Interventions

Home | CRT2015 | CardioTube | Interesting Cases | Trials | Weekly Poll Archive | Newsletter Archive | Login


Copyright © 2015, CRTONLINE - About / Contact Us. All rights reserved. Privacy Policy
Powered by Multiweb